Oral nano‐curcumin formulation efficacy in the management of mild to moderate outpatient COVID‐19: A randomized triple‐blind placebo‐controlled clinical trial

Oral nano‐curcumin formulation efficacy in the management of mild to moderate outpatient COVID‐19: A randomized triple‐blind placebo‐controlled clinical trial

Abstract Background Curcumin, a natural polyphenolic compound, is proposed as a potential treatment option for patients with coronavirus disease by inhibiting the entry of virus to the cell, encapsulation of the virus and viral protease, as well as modulating various cellular signaling pathways. In...

Full description

Bibliographic Details
Main Authors: Reza Ahmadi, Soofia Salari, Mohammad Davood Sharifi, Hamidreza Reihani, Mohammad Bagher Rostamiani, Morteza Behmadi, Zhila Taherzadeh, Saeed Eslami, Seyed Mahdi Rezayat, Mahmoud Reza Jaafari, Sepideh Elyasi
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:Food Science & Nutrition
Subjects:
anti‐inflammatory
clinical response
COVID‐19
Curcumin
Online Access:https://doi.org/10.1002/fsn3.2226

Internet

https://doi.org/10.1002/fsn3.2226

Similar Items